Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver I Schmidt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Brain Research. Brain Research Reviews|April 27, 2005
Closed head injury--an inflammatory disease?Oliver I Schmidt, Christoph E Heyde, Wolfgang Ertel, et al.
World Journal of Emergency Surgery : WJES|March 5, 2009
ATLS(R) and damage control in spine traumaOliver I Schmidt, Ralf H Gahr, Andreas Gosse, et al.
Indian Journal of Orthopaedics|December 9, 2010
Role of early minimal-invasive spine fixation in acute thoracic and lumbar spine traumaOliver I Schmidt, Sergej Strasser, Victoria Kaufmann, et al.
Trends in Neurosciences|July 19, 2005
IL-18: a key player in neuroinflammation and neurodegeneration?Ursula Felderhoff-Mueser, Oliver I Schmidt, Andreas Oberholzer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 16, 2003
Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic miceMario Rancan, Maria C Morganti-Kossmann, Scott R Barnum, et al.
Journal of Neuroinflammation|August 3, 2004
Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injuryOliver I Schmidt, Maria Cristina Morganti-Kossmann, Christoph E Heyde, et al.
Experimental Neurology|March 21, 2006
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injuryIris Leinhase, Oliver I Schmidt, Joshua M Thurman, et al.
Journal of Neuroinflammation|January 10, 2009
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in micePhilip F Stahel, Michael A Flierl, B Paul Morgan, et al.
Journal of Neuroinflammation|May 4, 2007
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in miceIris Leinhase, Michal Rozanski, Denise Harhausen, et al.
BMC Neuroscience|July 18, 2006
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activationIris Leinhase, V Michael Holers, Joshua M Thurman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Brain Research. Brain Research Reviews|April 27, 2005
Closed head injury--an inflammatory disease?Oliver I Schmidt, Christoph E Heyde, Wolfgang Ertel, et al.
World Journal of Emergency Surgery : WJES|March 5, 2009
ATLS(R) and damage control in spine traumaOliver I Schmidt, Ralf H Gahr, Andreas Gosse, et al.
Indian Journal of Orthopaedics|December 9, 2010
Role of early minimal-invasive spine fixation in acute thoracic and lumbar spine traumaOliver I Schmidt, Sergej Strasser, Victoria Kaufmann, et al.
Trends in Neurosciences|July 19, 2005
IL-18: a key player in neuroinflammation and neurodegeneration?Ursula Felderhoff-Mueser, Oliver I Schmidt, Andreas Oberholzer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 16, 2003
Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic miceMario Rancan, Maria C Morganti-Kossmann, Scott R Barnum, et al.
Journal of Neuroinflammation|August 3, 2004
Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injuryOliver I Schmidt, Maria Cristina Morganti-Kossmann, Christoph E Heyde, et al.
Experimental Neurology|March 21, 2006
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injuryIris Leinhase, Oliver I Schmidt, Joshua M Thurman, et al.
Journal of Neuroinflammation|January 10, 2009
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in micePhilip F Stahel, Michael A Flierl, B Paul Morgan, et al.
Journal of Neuroinflammation|May 4, 2007
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in miceIris Leinhase, Michal Rozanski, Denise Harhausen, et al.
BMC Neuroscience|July 18, 2006
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activationIris Leinhase, V Michael Holers, Joshua M Thurman, et al.
Pageof 1